Resona Asset Management Co. Ltd. Takes $10.12 Million Position in Humana Inc. (NYSE:HUM)

Resona Asset Management Co. Ltd. bought a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 39,837 shares of the insurance provider’s stock, valued at approximately $10,117,000.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the period. Norges Bank acquired a new stake in Humana during the fourth quarter worth about $416,202,000. Pzena Investment Management LLC grew its position in Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after buying an additional 1,103,132 shares in the last quarter. Boston Partners increased its stake in Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after acquiring an additional 893,637 shares during the period. Finally, Artisan Partners Limited Partnership raised its holdings in Humana by 83.4% in the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock valued at $170,928,000 after acquiring an additional 306,433 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of Humana stock opened at $253.37 on Monday. The firm has a fifty day moving average of $267.58 and a two-hundred day moving average of $271.55. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $30.58 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 2.05 and a beta of 0.62. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Truist Financial lifted their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Barclays boosted their price target on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Morgan Stanley decreased their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Finally, StockNews.com cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Eighteen investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $280.17.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.